Vectors in Gene Therapy

The delivery of genes into DNA for gene therapy is done through the use of vectors, which are often viral vectors. These vectors can be manipulated to include DNA and RNA depending on the type of therapy that is needed. Here is the latest research on vector gene therapy.

April 17, 2021
Open Access

Generative AAV capsid diversification by latent interpolation

BioRxiv : the Preprint Server for Biology
S. SinaiEric D Kelsic
April 18, 2021

Delivering AAV to the Central Nervous and Sensory Systems.

Trends in Pharmacological Sciences
Cole W PetersKillian S Hanlon
April 16, 2021

Nanomedicines for combating multidrug resistance of cancer.

Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
Ya-Xuan ZhuFu-Gen Wu
April 16, 2021
Open Access

GM1 Gangliosidosis: Mechanisms and Management.

The Application of Clinical Genetics
Allisandra K RhaDouglas R Martin
April 16, 2021

Vector engineering, strategies and targets in cancer gene therapy.

Cancer Gene Therapy
Vijayata SinghGiridhara R Jayandharan
April 16, 2021

Herpes Simplex Virus Type 1 Co-Infection Modifies Adeno-Associated Virus Genome End Recombination.

Journal of Virology
Anita Felicitas MeierCornel Fraefel
April 16, 2021

Exploration of p53 plus interferon-beta gene transfer for the sensitization of human colorectal cancer cell lines to cell death.

Cancer Biology & Therapy
Paulo Roberto Del ValleBryan E Strauss
April 14, 2021
Open Access

AAV-delivery of diacylglycerol kinase kappa achieves long-term rescue of Fmr1-KO mouse model deficits of fragile X syndrome

BioRxiv : the Preprint Server for Biology
Karima HabbasH. Moine
April 14, 2021
Open Access

AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa.

Yunlu XueConstance L Cepko
April 12, 2021
Open Access

CRISPR-Cas is associated with fewer antibiotic resistance genes in bacterial pathogens

BioRxiv : the Preprint Server for Biology
Elizabeth PurseyS. van Houte

Sign up to follow this feed and discover related papers.

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

© 2021 Meta ULC. All rights reserved